A Phase II Study of BMS-354825 in Subjects with Myeloid Blast Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

  • Brown, Randy (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/056/30/07